In univariate analysis, tumour PD-L1 was associated with DCB, especially in the patients with ≥50% tumour PD-L1 expression (DCB rate 75%, OR 13.6, 95% CI 2.3–79.0) (Fig. 1c and Table 2). Here, CD274 is linked to neoplasm.